Navigation Links
Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
Date:9/11/2013

(PRWEB) September 11, 2013

A federal panel of judges, after three months of deliberation, denied a motion for consolidation of Lipitor-induced Type 2 diabetes cases, according to an Aug. 8 panel order.* The Rottenstein Law Group LLP, a Lipitor law firm, offers an explanation of what the decision means for those looking to file Lipitor lawsuits.

The U.S. Judicial Panel on Multidistrict Litigation oversees consolidations of federal lawsuits. In its order, the JPML wrote that, “in particular, almost half of the actions currently comprising this litigation are pending in a single district—the District of South Carolina, and many of the actions involve common plaintiffs’ counsel. The South Carolina actions already are proceeding in a coordinated fashion before one judge.”

In the order, the JPML also indicated that Pfizer was willing to coordinate with the plaintiffs with regard to the consolidation of pretrial proceedings such as common discovery, which is the primary purpose of a multidistrict litigation. Therefore, the JPML denied the motion to create an MDL, according to the order.

“The decision of the Panel isn’t controversial, and it certainly should not be discouraging to any potential plaintiff,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “The Panel saw that there are currently a small number of Lipitor suits, most of which are already in the same court. Anyone who has taken Lipitor and suffered adverse side effects has the same opportunity to sue for compensation as always. The Panel decision doesn’t change that at all.”

The Lipitor lawsuits focus on the claim, supported by at least two research studies, that links the use of the drug and a risk of Type 2 diabetes. A 2011 American College of Cardiology study established a connection between the statin and the diabetes risk, and a January 2012 JAMA: Internal Medicine study highlighted the risk in women.**

The Rottenstein Law Group LLP encourages those who have taken Lipitor to download a free informational brochure that discusses Lipitor side effects and how to file a Lipitor lawsuit.

*In Re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation, MDL-2459, JPML. http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2459-Denied_Transfer-07-13.pdf

**archinte.jamanetwork.com/article.aspx?articleid=1108676

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
                            ###

Read the full story at http://www.prweb.com/releases/lipitor-lawsuits/diabetes/prweb11110224.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
2. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
3. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
4. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
5. Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
6. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
7. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
8. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
9. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
10. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
11. Actos Lawsuit Filed By Wright & Schulte on Behalf of Ohio Man Alleges Extended Use of Type-2 Diabetes Drug Caused Him to Develop Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: